Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 17 - Drugs for dermatological disorders
Patents for A61P 17 - Drugs for dermatological disorders (106,455)
10/2000
10/26/2000WO2000063157A1 Disubstituted benzene derivatives
10/26/2000WO2000063153A1 New compounds, their preparation and use
10/26/2000WO2000063148A1 Salts of asiatic and madecassic acid suitable for the preparation of pharmaceutical and cosmetic compositions
10/26/2000WO2000062789A1 Peptide extract of lupine and pharmaceutical or cosmetic or nutritional composition comprising same
10/26/2000WO2000062788A2 Treatment of hypersensitivity reaction disorders
10/26/2000WO2000062784A1 Pharmaceutical composition on the basis of erythromycin fatty acid salts for the topical treatment of skin diseases
10/26/2000WO2000062781A1 Medicaments containing inhibitors of cell-volume regulated human kinase h-sgk
10/26/2000WO2000062778A1 Cyclic protein tyrosine kinase inhibitors
10/26/2000WO2000062770A1 Compounds useful as phosphotyrosine mimics
10/26/2000WO2000062767A2 Pharmaceutical compositions containing pyridine or pyrimidine derivates for inhibition of cytokine production and secretion
10/26/2000WO2000062766A2 Uses of ppar-gamma agonists in neutrophil-induced diseases
10/26/2000WO2000062753A1 Pharmaceutical or cosmetic compositions for the local, intradermal application of hormones
10/26/2000WO2000062744A2 Skin care compositions containing combination of skin care actives
10/26/2000WO2000062743A2 Skin care compositions containing combination of skin care actives
10/26/2000WO2000062740A2 Skin care compositions containing combination of skin care actives
10/26/2000WO2000040719A3 Tissue repair protein involved in orofacial clefting and uses thereof
10/26/2000WO2000039275A3 Multiple shear stress responsive elements (ssre) and methods of use thereof
10/26/2000WO2000038695A3 Aciclovir compositions containing dimethicone
10/26/2000WO2000018230A9 Combination of bisphosphonate and tetracycline
10/26/2000WO2000017191A3 N-(iminomethyl)amine derivatives, their preparation, their use as medicines and compositions containing them
10/26/2000WO2000017190A3 Amidine derivatives, their preparation and application as medicines and pharmaceutical compositions containing same
10/26/2000DE19919308A1 Antipsoriatic composition containing proteolytic enzyme, preferably bromelain, removes harmful metabolites from epidermal basal layer cells to normalize skin structure
10/26/2000DE19917906A1 Verwendung von aminosubstituierten Hydroxybenzophenonen als photostabile UV-Filter in kosmetischen und pharmazeutischen Zubereitungen The use of amino-substituted hydroxybenzophenones as photostable UV filters in cosmetic and pharmaceutical preparations
10/26/2000DE19917548A1 Stable topical pharmaceutical composition for treating skin diseases, especially acne, contains erythromycin higher fatty acid salt in liquid or viscous carrier
10/26/2000CA2371399A1 Skin care compositions containing combination of skin care actives
10/26/2000CA2370713A1 Salts of asiatic and madecassic acid suitable for the preparation of pharmaceutical and cosmetic compositions
10/26/2000CA2370602A1 Adipocyte complement related protein homolog zacrp2
10/26/2000CA2370570A1 Dna encoding the human vanilloid receptor vr1
10/26/2000CA2370453A1 Treatment of hypersensitivity reaction disorders
10/26/2000CA2370417A1 Substituted azoles
10/26/2000CA2370301A1 Osteopontin-derived chemotactic and inhibitory agents and uses therefor
10/26/2000CA2370272A1 Protease activated receptor 2 variants
10/26/2000CA2370129A1 Methods and compositions for modulating an immune response
10/26/2000CA2370127A1 Novel method of treatment
10/26/2000CA2369078A1 Medicaments containing inhibitors of cell-volume regulated human kinase h-sgk
10/26/2000CA2367359A1 Dibenzoazulene derivatives for the treatment of thrombosis, osteoporosis, arteriosclerosis
10/26/2000CA2367356A1 New compounds, their preparation and use
10/26/2000CA2365949A1 Adhesion modulatory peptides and methods for use
10/26/2000CA2364209A1 49 human secreted proteins
10/26/2000CA2363689A1 Compounds useful as phosphotyrosine mimics
10/25/2000EP1046398A1 Preparation of a medicament containing polyphenol compounds of catechic or flavonylic type from plants, especially for the treatment of gingivitis
10/25/2000EP1046395A1 Plaster for topical use containing heparin and diclofenac
10/25/2000EP1046393A1 Composition containing at least one bicyclic aromatic compound and at least one 2-alkyl-1-alkanol or an ester, and its use
10/25/2000EP1046391A2 Use of aminosubstituted hydroxybenzophenones as photostable UV-filters in cosmetic and pharmaceutical preparations
10/25/2000EP1046389A1 Cosnetic composition in particular a make-up composition comprising a pyrrolopyrrole pigment
10/25/2000EP1045936A1 Aqueous compositions comprising complexing agents and uses therof
10/25/2000EP1045902A1 HUMAN SUPPRESSOR tRNA OLIGONUCLEOTIDES AND METHODS OF USE FOR SAME
10/25/2000EP1045845A1 N-oxides of heterocyclic compounds with tnf and pde-iv inhibiting activity
10/25/2000EP1045836A1 Pyridones as src family sh2 domain inhibitors
10/25/2000EP1045822A1 Certain diterpenes and extracts or concentrates of curcuma amada containing them for use as medicaments
10/25/2000EP1045697A2 Extension of cellular lifespan, methods and reagents
10/25/2000EP1045690A1 Benzenesulfonamide inhibitors of pde-iv and their therapeutic use
10/25/2000EP1045681A1 METHOD AND COMPOSITIONS FOR $i(IN SITU) FORMATION OF PROTECTIVE AND/OR MEDICATED FILMS ON BODY TISSUE
10/25/2000EP1014998A4 Polymeric compositions
10/25/2000EP0714418B1 Cosmetic melanins
10/25/2000CN1271285A Remedial agent for baldness and other diseases
10/25/2000CN1271279A Amide derivatives for the treatment of diseases mediated by cytokines
10/25/2000CN1270834A Wound healing ointment
10/25/2000CN1270823A Scald treating medicine powder
10/25/2000CN1270812A Burn and scald treating medicine and its preparation
10/25/2000CN1057685C Chinese medicine preparation for treating hemorrhoid and fistula
10/25/2000CN1057684C Germicidal anti-inflammatory myogenic plaster for external use and preparation method thereof
10/24/2000US6136985 CLA esters and uses thereof
10/24/2000US6136974 Pyrrolo[3,4-D]Pyrimidinone derivatives and their use as medicaments
10/24/2000US6136863 Antifungal agents
10/24/2000US6136851 Skin disorders
10/24/2000US6136848 Antiallergens; asthma therapy
10/24/2000US6136787 Interleukin 1β protease and interleukin 1β protease inhibitors
10/24/2000US6136596 Cytokine-, stress-, and oncoprotein-activated human protein kinase kinases
10/24/2000US6136574 Methods and compositions for synthesis of long chain polyunsaturated fatty acids
10/24/2000US6136332 Dermatological/pharmaceutical compositions comprising volatile oils/phenylated silicone oils
10/24/2000CA2179628C Psoriasis treatment
10/22/2000CA2306337A1 Cosmetic compound, namely make-up compound, containing a pigment derived from pyrrolopyrrole
10/19/2000WO2000061779A1 49 human secreted proteins
10/19/2000WO2000061774A2 Bone morphogenic proteins
10/19/2000WO2000061757A1 Tumor necrosis factor homologs and nucleic acids encoding the same
10/19/2000WO2000061755A2 Secreted human proteins
10/19/2000WO2000061754A2 Human proteins and polynucleotides encoding them
10/19/2000WO2000061750A2 TYROSINE KINASE SUBSTRATE (Tks) PROTEINS
10/19/2000WO2000061748A1 48 human secreted proteins
10/19/2000WO2000061628A1 49 human secreted proteins
10/19/2000WO2000061627A1 49 human secreted proteins
10/19/2000WO2000061621A2 Flea head, nerve cord, hindgut and malpighian tubule nucleic acid molecules, proteins and uses thereof
10/19/2000WO2000061620A1 49 human secreted proteins
10/19/2000WO2000061608A2 Low-molecular inhibitors of complement proteases
10/19/2000WO2000061604A2 Pharmaceutical compounds
10/19/2000WO2000061596A1 50 human secreted proteins
10/19/2000WO2000061592A1 Monosulphates of 4 or 6 disaccharides
10/19/2000WO2000061587A1 Pyrido-thieno-diazepines, method for the production thereof and pharmaceutical compositions containing said pyrido-thieno-diazepines
10/19/2000WO2000061583A1 Xanthine derivatives and analogs as cell signaling inhibitors
10/19/2000WO2000061580A1 Substituted bicyclic heteroaryl compounds as integrin antagonists
10/19/2000WO2000061576A1 Triarylimidazoles
10/19/2000WO2000061551A2 Pyrimidine-2-one derivatives as integrin receptor ligands
10/19/2000WO2000061545A1 Methods for solid phase combinatorial synthesis of integrin inhibitors
10/19/2000WO2000061542A1 Caspase inhibitors and the use thereof
10/19/2000WO2000061541A2 Pharmaceutical compounds
10/19/2000WO2000061221A1 Method of providing cosmetic/medical therapy
10/19/2000WO2000061180A2 Products and methods for treating ptp lar related diseases
10/19/2000WO2000061175A2 Use of pegylated interferon alpha in melanoma therapy
10/19/2000WO2000061171A2 Uses of mammalian ox2 protein and related reagents
1 ... 905 906 907 908 909 910 911 912 913 914 915 916 917 918 919 920 921 922 923 924 925 ... 1065